School of Biological Sciences, Faculty of Science, Kadoorie Biological Sciences Building, The University of Hong Kong, Pokfulam, Hong Kong.
Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
Am J Physiol Gastrointest Liver Physiol. 2021 Dec 1;321(6):G639-G655. doi: 10.1152/ajpgi.00226.2021. Epub 2021 Oct 13.
Emerging evidence links dietary fiber with altered gut microbiota composition and bile acid signaling in maintaining metabolic health. Yeast β-glucan (Y-BG) is a dietary supplement known for its immunomodulatory effect, yet its impact on the gut microbiota and bile acid composition remains unclear. This study investigated whether dietary forms of Y-BG modulate these gut-derived signals. We performed 4-wk dietary supplementation in healthy mice to evaluate the effects of different fiber composition (soluble vs. particulate Y-BG) and dose (0.1% vs. 2%). We found that 2% particulate Y-BG induced robust gut microbiota community shifts with elevated liver mRNA abundance and bile acid synthesis. These diet-induced responses were notably different when compared with the prebiotic inulin, and included a marked reduction in fecal abundance which we demonstrated as translatable to obesity in population-scale American Gut and TwinsUK clinical cohorts. This prompted us to test whether 2% Y-BG maintained metabolic health in mice fed 60% HFD over 13 wk. Y-BG consistently altered the gut microbiota composition and reduced abundance, with trends observed in improvement of metabolic phenotype. Notably, Y-BG improved insulin sensitization and this was associated with enhanced ileal mRNA accumulation and reduced abundance. Collectively, our results demonstrate that Y-BG modulates gut microbiota community composition and bile acid signaling, but the dietary regime needs to be optimized to facilitate clinical improvement in metabolic phenotype in an aggressive high-fat diet animal model. The study shows that dietary Y-BG supplementation modulated gut microbiota, bile acid metabolism and associated signaling pathways. Y-BG significantly reduced abundance which is associated with obesity in human cohorts. Correlation analysis confirmed functional interactions between bile acid composition, gut microbiota, and metabolic phenotype, although clinical benefit did not reach significance in an aggressive obesity model. Gut microbiota and bile acids correlated with metabolic parameters, indicating future potential of dietary Y-BG modulation of metabolic pathways.
越来越多的证据表明,膳食纤维通过改变肠道微生物群落组成和胆汁酸信号来维持代谢健康。酵母β-葡聚糖(Y-BG)是一种众所周知的具有免疫调节作用的膳食补充剂,但它对肠道微生物群落和胆汁酸组成的影响尚不清楚。本研究旨在探讨膳食形式的 Y-BG 是否会调节这些肠道来源的信号。我们在健康小鼠中进行了为期 4 周的饮食补充,以评估不同纤维组成(可溶性与颗粒状 Y-BG)和剂量(0.1%与 2%)的影响。我们发现,2%颗粒状 Y-BG 诱导了强烈的肠道微生物群落变化,导致肝脏 mRNA 丰度和胆汁酸合成增加。与益生元菊粉相比,这些饮食诱导的反应明显不同,包括粪便中丰度的显著降低,我们在人群规模的美国肠道和双胞胎英国临床队列中证明了这一点,可转化为肥胖。这促使我们测试 2%Y-BG 是否能在喂食 60%高脂肪饮食的小鼠中维持 13 周的代谢健康。Y-BG 持续改变肠道微生物群落组成并降低丰度,观察到代谢表型改善的趋势。值得注意的是,Y-BG 改善了胰岛素敏感性,这与回肠中 mRNA 积累增加和丰度降低有关。总的来说,我们的结果表明,Y-BG 调节肠道微生物群落组成和胆汁酸信号,但需要优化饮食方案,以促进在侵袭性高脂肪饮食动物模型中改善代谢表型。该研究表明,膳食 Y-BG 补充剂调节肠道微生物群、胆汁酸代谢和相关信号通路。Y-BG 显著降低了丰度,这与人类队列中的肥胖有关。相关性分析证实了胆汁酸组成、肠道微生物群和代谢表型之间的功能相互作用,尽管在侵袭性肥胖模型中,临床益处没有达到显著水平。肠道微生物群和胆汁酸与代谢参数相关,表明膳食 Y-BG 调节代谢途径的未来潜力。
Am J Physiol Gastrointest Liver Physiol. 2021-12-1
Mol Metab. 2016-10-13
Food Chem X. 2022-7-8
Microbiol Spectr. 2022-8-31